Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia

Related Experiment Video

Updated: May 12, 2026

Isolation and Activation of Murine Lymphocytes
08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

Ghasem Ghalamfarsa1, Farhad Jadidi-Niaragh, Mohammad Hojjat-Farsangi

  • 1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Cytokine
|April 13, 2013
PubMed

Insights

Interleukin-21 (IL21) differentially affects chronic lymphocytic leukemia (CLL) B cells. While it enhances proliferation with CpG in most patients, IL21 inhibits it in progressive CLL, suggesting therapeutic potential.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Interleukin-21 (IL21) influences B-cell functions, with known pro-apoptotic effects on chronic lymphocytic leukemia (CLL) B cells.
  • The specific role of IL21 in leukemic B cells from progressive versus non-progressive CLL patients remains largely uncharacterized.

Purpose of the Study:

  • To investigate the proliferative effects of IL21 in combination with a TLR9 agonist (CpG) on B cells from CLL patients and healthy controls.
  • To compare these effects between different CLL patient subsets, including progressive vs. non-progressive and mutated vs. unmutated IGHV.

Main Methods:

  • B cells were isolated from 24 CLL patients and 8 healthy controls using magnetic bead-based negative selection.
  • Proliferation was assessed via radioactive thymidine incorporation assay.
  • Immunophenotyping was performed using flow cytometry.

Main Results:

  • IL21 enhanced CpG-induced proliferation in both normal and CLL B cells, with no significant difference between patients and controls.
  • The combination of IL21 and CpG significantly inhibited B-cell proliferation in progressive CLL patients compared to non-progressive ones (p=0.001).
  • Conversely, IL21 and CpG enhanced proliferation in leukemic B cells from IGHV-mutated compared to unmutated patients (p=0.001).
  • The observed inhibitory effects were independent of apoptosis.

Conclusions:

  • IL21 exhibits differential biological functions in distinct CLL patient subsets.
  • IL21's ability to inhibit proliferation in progressive CLL suggests potential therapeutic applications for this patient group.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...